Examples were represented by elastin fragments in the serum of fibrotic and cirrhotic patients, the correlation of LAM-P1 serum level with the degree of fibrosis progression and inflammation in ALD and NAFLD patients, and the high levels of biglycan in the serum of rat models of liver fibrosis. The gene discussed is ELN; the disease is metabolic dysfunction-associated steatotic liver disease.